BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 36384125)

  • 1. Estrone, the major postmenopausal estrogen, binds ERa to induce SNAI2, epithelial-to-mesenchymal transition, and ER+ breast cancer metastasis.
    Qureshi R; Picon-Ruiz M; Sho M; Van Booven D; Nunes de Paiva V; Diaz-Ruano AB; Ince TA; Slingerland J
    Cell Rep; 2022 Nov; 41(7):111672. PubMed ID: 36384125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The Major Pre- and Postmenopausal Estrogens Play Opposing Roles in Obesity-Driven Mammary Inflammation and Breast Cancer Development.
    Qureshi R; Picon-Ruiz M; Aurrekoetxea-Rodriguez I; Nunes de Paiva V; D'Amico M; Yoon H; Radhakrishnan R; Morata-Tarifa C; Ince T; Lippman ME; Thaller SR; Rodgers SE; Kesmodel S; Vivanco MDM; Slingerland JM
    Cell Metab; 2020 Jun; 31(6):1154-1172.e9. PubMed ID: 32492394
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Regulation of breast cancer metastasis by Runx2 and estrogen signaling: the role of SNAI2.
    Chimge NO; Baniwal SK; Little GH; Chen YB; Kahn M; Tripathy D; Borok Z; Frenkel B
    Breast Cancer Res; 2011; 13(6):R127. PubMed ID: 22151997
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SNAI2 upregulation is associated with an aggressive phenotype in fulvestrant-resistant breast cancer cells and is an indicator of poor response to endocrine therapy in estrogen receptor-positive metastatic breast cancer.
    Alves CL; Elias D; Lyng MB; Bak M; Ditzel HJ
    Breast Cancer Res; 2018 Jun; 20(1):60. PubMed ID: 29921289
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol and Estrone Have Different Biological Functions to Induce NF-κB-Driven Inflammation, EMT and Stemness in ER+ Cancer Cells.
    Diaz-Ruano AB; Martinez-Alarcon N; Perán M; Benabdellah K; Garcia-Martinez MLÁ; Preda O; Ramirez-Tortosa C; Gonzalez-Hernandez A; Marchal JA; Picon-Ruiz M
    Int J Mol Sci; 2023 Jan; 24(2):. PubMed ID: 36674737
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between estrogen receptors, 17 beta-hydroxysteroid dehydrogenase and estrogen content in human breast cancer.
    Abul-Hajj YJ
    Steroids; 1979 Aug; 34(2):217-25. PubMed ID: 494363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of 17beta-hydroxysteroid dehydrogenases and other estrogen-metabolizing enzymes in different cancer cell lines.
    Smuc T; Rizner TL
    Chem Biol Interact; 2009 Mar; 178(1-3):228-33. PubMed ID: 19022235
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estrogen receptor-α-miR-1271-SNAI2 feedback loop regulates transforming growth factor-β-induced breast cancer progression.
    Liu BW; Yu ZH; Chen AX; Chi JR; Ge J; Yu Y; Cao XC
    J Exp Clin Cancer Res; 2019 Mar; 38(1):109. PubMed ID: 30823890
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SNAIL is induced by tamoxifen and leads to growth inhibition in invasive lobular breast carcinoma.
    Bossart EA; Tasdemir N; Sikora MJ; Bahreini A; Levine KM; Chen J; Basudan A; Jacobsen BM; Burns TF; Oesterreich S
    Breast Cancer Res Treat; 2019 Jun; 175(2):327-337. PubMed ID: 30798422
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Overexpression of 17β-hydroxysteroid dehydrogenase type 1 increases the exposure of endometrial cancer to 17β-estradiol.
    Cornel KM; Kruitwagen RF; Delvoux B; Visconti L; Van de Vijver KK; Day JM; Van Gorp T; Hermans RJ; Dunselman GA; Romano A
    J Clin Endocrinol Metab; 2012 Apr; 97(4):E591-601. PubMed ID: 22362820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reductive 17beta-hydroxysteroid dehydrogenases which synthesize estradiol and inactivate dihydrotestosterone constitute major and concerted players in ER+ breast cancer cells.
    Zhang CY; Wang WQ; Chen J; Lin SX
    J Steroid Biochem Mol Biol; 2015 Jun; 150():24-34. PubMed ID: 25257817
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estradiol and estrone C-16 derivatives as inhibitors of type 1 17beta-hydroxysteroid dehydrogenase: blocking of ER+ breast cancer cell proliferation induced by estrone.
    Laplante Y; Cadot C; Fournier MA; Poirier D
    Bioorg Med Chem; 2008 Feb; 16(4):1849-60. PubMed ID: 18035543
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estrogen and androgen-converting enzymes 17β-hydroxysteroid dehydrogenase and their involvement in cancer: with a special focus on 17β-hydroxysteroid dehydrogenase type 1, 2, and breast cancer.
    Hilborn E; Stål O; Jansson A
    Oncotarget; 2017 May; 8(18):30552-30562. PubMed ID: 28430630
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bioassays for estrogenic activity: development and validation of estrogen receptor (ERalpha/ERbeta) and breast cancer proliferation bioassays to measure serum estrogenic activity in clinical studies.
    Li J; Lee L; Gong Y; Shen P; Wong SP; Wise SD; Yong EL
    Assay Drug Dev Technol; 2009 Feb; 7(1):80-9. PubMed ID: 19382890
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new nonestrogenic steroidal inhibitor of 17β-hydroxysteroid dehydrogenase type I blocks the estrogen-dependent breast cancer tumor growth induced by estrone.
    Ayan D; Maltais R; Roy J; Poirier D
    Mol Cancer Ther; 2012 Oct; 11(10):2096-104. PubMed ID: 22914440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. New development in intracrinology of breast carcinoma.
    Sasano H; Suzuki T; Nakata T; Moriya T
    Breast Cancer; 2006; 13(2):129-36. PubMed ID: 16755106
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrone/17beta-estradiol conversion to, and tumor necrosis factor inhibition by, estrogen metabolites in synovial cells of patients with rheumatoid arthritis and patients with osteoarthritis.
    Schmidt M; Hartung R; Capellino S; Cutolo M; Pfeifer-Leeg A; Straub RH
    Arthritis Rheum; 2009 Oct; 60(10):2913-22. PubMed ID: 19790073
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of nomegestrol acetate on estrogen biosynthesis and transformation in MCF-7 and T47-D breast cancer cells.
    Shields-Botella J; Chetrite G; Meschi S; Pasqualini JR
    J Steroid Biochem Mol Biol; 2005 Jan; 93(1):1-13. PubMed ID: 15748827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 17Beta-hydroxysteroid dehydrogenase enzymes and breast cancer.
    Jansson A
    J Steroid Biochem Mol Biol; 2009 Mar; 114(1-2):64-7. PubMed ID: 19167496
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent data on intratumor estrogens in breast cancer.
    Lønning PE; Haynes BP; Straume AH; Dunbier A; Helle H; Knappskog S; Dowsett M
    Steroids; 2011 Jul; 76(8):786-91. PubMed ID: 21439992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.